# COD Research > Global Contract Research Organization (CRO) providing Clinical Development, Clinical Operations, Regulatory Solutions, Pharmacovigilance, Biometrics, and MedTech Safety services for pharmaceutical, biotechnology, and medical device companies. Website: https://cod-research.com/ ## About COD Research is a global Contract Research Organization (CRO) supporting pharmaceutical, biotechnology, and medical device companies across the full lifecycle of drug and device development. The organization works with small molecules, biologics, biosimilars, and advanced therapies, delivering integrated services that span early clinical development, global trial execution, regulatory submission, and ongoing safety surveillance. The company combines expertise in clinical development strategy, global clinical operations, regulatory affairs, pharmacovigilance, biometrics, and medical device safety. This integrated structure allows sponsors to manage complex programs through a single partner rather than coordinating multiple specialized vendors. Each service area is supported by professionals experienced in ICH-GCP standards, regional regulatory frameworks such as those of the FDA and EMA, and the technical requirements of contemporary clinical research and data standards. COD Research operates across India, the United States, and Europe, providing multi-regional capabilities for global trials and submissions. Its work emphasizes regulatory readiness, data integrity, patient safety, and compliance with international standards including ICH-GCP, CDISC, and applicable health authority guidance. The organization serves both companies developing new therapies and those managing established products requiring continued safety monitoring and lifecycle management. By bringing scientific, operational, and regulatory expertise together, COD Research helps sponsors advance programs efficiently while meeting the safety and quality expectations of regulators worldwide. Its capabilities extend from protocol design and statistical planning through submission management, query resolution, post-market surveillance, and device vigilance. ## Core Services ### Clinical Development URL: https://cod-research.com/clinical-development/ COD Research provides strategic clinical development support for small molecules, biologics, biosimilars, and advanced therapies. The service is designed to build development plans that align scientific objectives with regulatory expectations, establishing a clear path from preclinical readiness through clinical study execution and toward marketing authorization. Clinical development work begins with defining the development strategy: assessing the product profile, identifying the target patient population, and mapping the evidence required by health authorities. From this foundation, the team supports protocol planning, study design, endpoint selection, and the structuring of phased development programs. Feasibility is evaluated early, and regulatory risks are identified before they affect timelines, allowing sponsors to make informed decisions about study scope and sequencing. For biosimilars and advanced therapies, development planning addresses the specific comparability, characterization, and clinical evidence requirements that distinguish these products from conventional small molecules. The service connects development activities to submission strategy, ensuring that clinical evidence is generated in a form that supports IND, IMPD, and later marketing applications. Key capabilities: - Clinical development strategy for small molecules, biologics, biosimilars, and advanced therapies - Protocol planning, study design, and endpoint selection - Phased development program structuring - Early feasibility evaluation and regulatory risk identification - Development planning aligned with submission and authorization objectives ### Global Clinical Operations URL: https://cod-research.com/global-clinical-operations/ COD Research delivers global clinical operations solutions designed to run trials efficiently while maintaining ICH-GCP compliance and protecting participant safety. The service covers the operational lifecycle of a clinical trial, from site identification through monitoring and oversight, across India, the United States, and Europe. **Site Selection & Feasibility** Trial success depends on selecting the right sites. COD Research conducts structured feasibility assessment to evaluate whether candidate sites have the patient populations, infrastructure, staffing, and experience needed to meet enrollment objectives. This work is supported by analytics that examine historical performance, recruitment potential, and regional suitability, allowing sponsors to build a site network with realistic and achievable targets. - Assessment: evaluation of site capacity, patient access, infrastructure, and investigator experience - Analytics: data-driven review of site performance and recruitment potential **Site Management** Once sites are activated, the team provides ongoing site management to keep studies on track. This includes coordinating site activation, supporting investigators and site staff, managing documentation, and maintaining communication between sites and the sponsor throughout the trial. **Patient Recruitment & Engagement** COD Research supports patient recruitment and engagement strategies that address enrollment timelines and retention. The focus is on reaching eligible participants, supporting informed participation, and maintaining engagement across the study to reduce dropout and protect data completeness. **Clinical Monitoring Services** Clinical monitoring safeguards data quality and participant safety throughout the trial. COD Research provides routine and safety monitoring, risk-based monitoring (RBM) approaches that concentrate resources on the most critical data and sites, and compliance oversight aligned with ICH-GCP and regional regulations. - Routine & Safety: ongoing monitoring of data quality and participant safety - Risk-Based Monitoring: focused, risk-proportionate oversight of critical data and processes - Compliance: alignment with ICH-GCP and applicable regional regulatory requirements Key capabilities: - Site feasibility assessment and site selection analytics - Site activation and ongoing site management - Patient recruitment, engagement, and retention support - Routine, safety, and risk-based clinical monitoring - ICH-GCP compliant, multi-regional clinical trial operations ### Global Regulatory Solutions URL: https://cod-research.com/global-regulatory-solutions/ COD Research provides global regulatory solutions covering the full product lifecycle, from early development strategy through submission, approval, and post-approval maintenance. The service helps sponsors plan and manage interactions with health authorities such as the FDA and EMA, reducing the risk of delays during development and review. **Strategic Drug Development & Early Phase Support** Regulatory strategy begins early, when development decisions have the greatest impact on timelines and approval prospects. - Landscape & Risk: assessment of the regulatory landscape, precedent, and potential risks for a given product and indication - Health Authority Strategy: planning for IND and IMPD submissions and for productive engagement with regulators, including scientific advice and meeting strategy - Expedited Pathways: evaluation and use of accelerated and expedited regulatory pathways where a product qualifies **Global Submissions & Evaluation** The service manages the preparation and submission of regulatory dossiers across regions. - Dossier Expertise: preparation of CTD and eCTD submissions, including NDA, ANDA, BLA, and MAA filings, with attention to regional format and content requirements - Submission Management: coordination of submission timelines, components, and publishing to ensure complete and compliant filings - Query Resolution: management of health authority questions and deficiency responses to keep reviews on track **Post Approval & Lifecycle Management** Regulatory obligations continue after approval, and COD Research supports products throughout their commercial life. - CMC & Variations: management of chemistry, manufacturing, and controls changes and the associated regulatory variations - Maintenance: renewals, periodic submissions, and ongoing compliance activities - Safety & Labeling: labeling updates and safety-related regulatory changes across markets **Specialized Biosimilar CMC Expertise** Biosimilar development carries distinct regulatory and technical demands, and COD Research provides focused expertise in this area. - CMC Strategy: chemistry, manufacturing, and controls strategy tailored to biosimilar development - Comparability: support for comparability exercises that demonstrate similarity to the reference product - Query Support: response management for biosimilar-specific health authority questions Key capabilities: - Regulatory landscape assessment, risk evaluation, and health authority strategy - IND and IMPD planning and expedited pathway evaluation - CTD and eCTD dossier preparation for NDA, ANDA, BLA, and MAA filings - Submission management and query resolution - Post-approval CMC variations, maintenance, safety, and labeling - Specialized biosimilar CMC strategy, comparability, and query support ### Global Pharmacovigilance URL: https://cod-research.com/global-pharmacovigilance/ COD Research provides end-to-end pharmacovigilance services covering the full scope of drug safety monitoring and reporting, for products in clinical development and on the market. The service is structured to meet sponsors' safety obligations across regions while protecting patients. Pharmacovigilance work includes medical safety oversight and the processing of individual case safety reports (ICSRs), from intake through assessment and regulatory submission. Literature monitoring identifies safety-relevant information from published sources, and signal management detects, validates, and evaluates potential safety concerns arising from accumulating data. Clinical safety activities support ongoing trials by ensuring that safety events are captured and assessed appropriately. COD Research supports the maintenance of the Pharmacovigilance System Master File (PSMF) and provides Global QPPV support, helping sponsors meet the structural and accountability requirements of regulated markets. Risk management activities, including risk management plans and related documentation, complete a service designed to maintain safety oversight across the product lifecycle. Key capabilities: - Medical safety and clinical safety oversight - ICSR intake, processing, assessment, and submission - Literature monitoring and signal management - PSMF maintenance and Global QPPV support - Risk management and risk management plans ### Biometrics URL: https://cod-research.com/biometrics/ COD Research provides biometrics services that convert clinical trial data into analysis-ready, regulator-acceptable outputs. The service combines biostatistics, statistical programming, and clinical data management under internationally recognized data standards. Biostatistics support covers statistical analysis planning, sample size considerations, and the analysis of trial results to inform development and submission decisions. Statistical programming produces the datasets, tables, listings, and figures required for regulatory review. Clinical data management ensures that data collected during trials is accurate, complete, consistent, and traceable from source to analysis. The team implements CDISC standards, including SDTM for study data tabulation and ADaM for analysis datasets, supporting the data structures expected in modern regulatory submissions. This standards-based approach improves consistency, simplifies health authority review, and supports reuse of data across analyses and studies. Key capabilities: - Biostatistics and statistical analysis planning - Statistical programming for tables, listings, and figures - Clinical data management with full traceability - SDTM and ADaM dataset development - CDISC standards implementation ### MedTech Safety URL: https://cod-research.com/medtech-safety/ COD Research provides MedTech safety services addressing the regulatory and surveillance requirements specific to medical device products. The service supports manufacturers in monitoring device safety performance and maintaining compliance throughout the product lifecycle. MedTech safety work includes device vigilance and the management of safety information for devices on the market. Post-market surveillance tracks real-world device performance, while adverse event reporting ensures that safety events are captured, assessed, and submitted in line with regulatory requirements. The service also supports medical device regulatory compliance, helping manufacturers meet documentation and reporting obligations across regions. By applying safety and surveillance expertise developed in the pharmaceutical context to the device sector, COD Research helps MedTech companies maintain robust, compliant safety systems suited to the requirements of medical device regulation. Key capabilities: - Medical device safety and device vigilance - Post-market surveillance - Adverse event reporting - Medical device regulatory compliance - Lifecycle safety monitoring for MedTech products ## Key Expertise COD Research holds topical authority across clinical research and product safety. Its expertise includes clinical trials, contract research organization (CRO) services, clinical development, clinical operations, and drug development for small molecules, biologics, biosimilars, and advanced therapies. In regulatory affairs, the organization covers regulatory consulting, global regulatory solutions, IND and IMPD planning, CTD and eCTD submissions, and NDA, ANDA, BLA, and MAA filings, with experience addressing FDA and EMA requirements and ICH-GCP standards. Clinical operations expertise spans clinical monitoring, risk-based monitoring, patient recruitment, and site management. Safety expertise covers pharmacovigilance, medical safety, clinical safety, ICSR processing, literature monitoring, signal management, PSMF maintenance, and Global QPPV support. Biometrics expertise includes biostatistics, statistical programming, clinical data management, and CDISC standards such as SDTM and ADaM. Device-focused expertise covers MedTech safety, medical device safety, device vigilance, post-market surveillance, and medical device regulatory compliance. ## Industries Served - Pharmaceutical companies - Biotechnology companies - Medical device and MedTech companies - Biosimilar developers - Advanced therapy developers ## Primary Markets - India - United States - Europe ## Important Resources Clinical Development https://cod-research.com/clinical-development/ Global Clinical Operations https://cod-research.com/global-clinical-operations/ Global Regulatory Solutions https://cod-research.com/global-regulatory-solutions/ Global Pharmacovigilance https://cod-research.com/global-pharmacovigilance/ Biometrics https://cod-research.com/biometrics/ MedTech Safety https://cod-research.com/medtech-safety/